A251120 Stock Overview
Develops active ingredients for anti-aging cosmetics in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
BIO-FD&C Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩13,760.00 |
| 52 Week High | ₩19,150.00 |
| 52 Week Low | ₩12,090.00 |
| Beta | 0.59 |
| 1 Month Change | -0.43% |
| 3 Month Change | -11.68% |
| 1 Year Change | 11.15% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -38.02% |
Recent News & Updates
With EPS Growth And More, BIO-FD&CLtd (KOSDAQ:251120) Makes An Interesting Case
Dec 16
We Think That There Are Some Issues For BIO-FD&CLtd (KOSDAQ:251120) Beyond Its Promising Earnings
Nov 19Recent updates
With EPS Growth And More, BIO-FD&CLtd (KOSDAQ:251120) Makes An Interesting Case
Dec 16We Think That There Are Some Issues For BIO-FD&CLtd (KOSDAQ:251120) Beyond Its Promising Earnings
Nov 19Some Shareholders Feeling Restless Over BIO-FD&C Co.,Ltd.'s (KOSDAQ:251120) P/E Ratio
Oct 14A Look At The Fair Value Of BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
Aug 06Shareholder Returns
| A251120 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -0.3% | 1.1% | -0.4% |
| 1Y | 11.1% | 27.5% | -0.7% |
Return vs Industry: A251120 underperformed the KR Biotechs industry which returned 27.5% over the past year.
Return vs Market: A251120 exceeded the KR Market which returned -0.7% over the past year.
Price Volatility
| A251120 volatility | |
|---|---|
| A251120 Average Weekly Movement | 4.9% |
| Biotechs Industry Average Movement | 8.7% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in KR Market | 12.9% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A251120 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A251120's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Sang-Hyun Mo | www.biofdnc.com |
BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, herbal extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, skin moisturizing, anti-inflammation/skin soothing, and anti-oxidation.
BIO-FD&C Co.,Ltd. Fundamentals Summary
| A251120 fundamental statistics | |
|---|---|
| Market cap | ₩119.65b |
| Earnings (TTM) | ₩5.10b |
| Revenue (TTM) | ₩16.07b |
23.5x
P/E Ratio7.4x
P/S RatioIs A251120 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A251120 income statement (TTM) | |
|---|---|
| Revenue | ₩16.07b |
| Cost of Revenue | ₩4.95b |
| Gross Profit | ₩11.12b |
| Other Expenses | ₩6.02b |
| Earnings | ₩5.10b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 586.36 |
| Gross Margin | 69.22% |
| Net Profit Margin | 31.74% |
| Debt/Equity Ratio | 2.0% |
How did A251120 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 02:42 |
| End of Day Share Price | 2025/01/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BIO-FD&C Co.,Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eui-Seob Shim | NH Investment & Securities Co., Ltd. |